Prediction of in-vivo blood level with controlled-release dosage forms. Effect of the gastrointestinal tract time

Journal of Pharmacy and Pharmacology

Volumn 48, Issue 4, 1996, Pages 390-394

  Ouriemchi, E M ^a   Vergnaud, J M ^a  

^a UNIVERSITÉ JEAN MONNET   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DIFFUSION; DOSE RESPONSE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG RELEASE; INTESTINE TRANSIT TIME; MATHEMATICAL MODEL; ORAL DRUG ADMINISTRATION; PREDICTION; SUSTAINED RELEASE PREPARATION;

EID: 0029946973     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1996.tb05939.x     Document Type: Article

References (20)

1. Abrahamsson, B., Alpsten, M., Hugasson, M., Jonsson, U. E., Sundgren, M., Svenheden, A., Tolli, J. (1993) Absorption, gastrointestinal transit, and tablet erosion of felodipine extended-release tablets. Pharm. Res. 10: 709-714
2. Aquiar, A., Wheeler, L. M., Fusari, S., Zelmer, J. E. (1968) Evaluation of physical and pharmaceutical factors involved in drug release and availability from chloramphenicol capsules. J. Pharm. Sci. 57: 1844-1850
3. Armand, J. Y., Magnard, F., Bouzon. J., Rollet, M., Taverdet, J. L., Vergnaud, J. M. (1987) Modelling of the release of drug in gastric liquid from galenic forms with Eudragit matrix. Int. J. Pharm. 40: 33-41
4. Bidah, D., Vergnaud, J. M. (1990) Kinetics of in vitro release of sodium salicylate dispersed in Gelucire. Int. J. Pharm. 58: 215 -220
5. Bidah, D., Ouriemchi, E. M., Vergnaud, J. M. (1992) Diffusional process of drug delivery from a dosage form with a Gelucire matrix. Int. J. Pharm. 80: 145-149
6. Dominguez-Gil, A. (1993) Contribution of biopharmaceutics and pharmacokinetics to improve drug therapy. Eur. J. Drug Metab. Pharmacol. 18: 1-5
7. Hamlin, W. E., Nelson. E., Ballard, B. E., Wagner. J. C. (1962) Loss of sensibility in distinguishing real differences in dissolution rates due to increasing agitation. J. Pharm. Sci. 51: 432-435
8. Heilman, K. (1984) Therapeutic Systems. Rate-controlled drug delivery: concept and development. Georg Thieme Verlag Publishers. Stuttgart, pp 1-23
9. Heller, J. (1984) Biodegradable polymers in controlled drug delivery: CRC. Crit. Rev. Ther. Drug Carrier Syst. 1: 39-90
10. Hüttenrauch, R., Speiser, P. (1985) In vitro/in vivo correlations: an unrealistic problem. Pharmacol. Res. 3: 97-102
11. Levy, G. (1961) Comparison of dissolution and absorption rates of different commercial aspirin tablets. J. Pharm. Sci. 52: 1039-1041
12. Nia, B., Ouriemchi, E. M., Vergnaud, J. M. (1995) Calculation of the blood level of a drug taken orally with a diffusion controlled dosage forms. Int. J. Pharm. 119: 165-171
13. Ouriemchi, E. M., Bouzon, J., Vergnaud. J. M. (1995) Modelling the process of controlled release of drug in vitro and in vivo tests. Int. J. Pharm. 113: 231-240
14. Siewert, M. (1993) Perspectives of in vitro dissolution tests in establishing in vivo/in vitro correlation. Eur. J. Drug Metab. Pharmacol. 18: 7-18
15. Skelly, J. P., Barr, W. H., Benel, L. Z., Doluisio.G., Lowenthal, D. T., Robinson, J. R., Shah, V. P., Temple, R. J., Yacoubi, A. (1987) Report of the workshop on controlled-release dosage forms: issues and controversies. Pharm. Res. 4: 75-77
16. Skelly, J. P., Amidon, G. L., Barr, W. H., Benet, L. Z., Carter, J. E. Robinson, J. R., Shah, V. P., Yacoubi, A. (1990): In vitro and in vivo testing and correlations for oral controlled, modified release dosage forms. Pharm. Res. 7: 975-982
17. Skelly, J. P., Shiu, G. H. (1993) In vitro/in vivo correlations in biopharmaceutics: scientific and regulatory implications. Eur. J. Drug. Metab. Pharmacol. 18: 121-129
18. Süverkrüp. R. (1986) In vitro/in vivo correlations: concepts and misconceptions. Acta Pharm. Technol. 32: 105-108
19. Vergnaud. J. M. (1993) Controlled Drug Release of Oral Dosage Forms. E. Horwood, Chichester, UK, pp 199-259
20. Vidai Dictionary (1994) Editions du Vidai, Paris, pp 115-117